Market & Investment | Support
Data-Driven Growth Potential & Global Partnership Opportunities
Market Outlook
Global Stem Cell Market
↗ 10.2% CAGR [cite_start]The global stem cell market is projected to grow from $13.7 billion (2019) to $23.96 billion by 2025[cite: 134, 151].
(Ref: PDF Page 8)
[cite_start]Key Driver: The Asian market (China, India, Japan, Korea) is showing the fastest growth rate due to government support and medical tourism[cite: 172].
Immuno-Cancer Medicine
↗ 19.0% CAGR [cite_start]The immuno-cancer drug market is expected to reach $48 billion by 2024, driven by the shift from chemical to targeted immune therapies[cite: 699, 704].
(Ref: PDF Page 29)
[cite_start]Trend: CAR-T cell therapy specifically is expected to grow at an annual average of 54%[cite: 587].
Investment Highlights: The Localization Advantage
Centerpiece Bio addresses the critical need for "Material Localization" in the Korean bio-market.
-
[cite_start]
- Import Substitution: We replace "Animal Serum" (FBS), which currently accounts for 90% of the market, with our patented Serum-Free Medium[cite: 186]. [cite_start]
- Supply Stability: Domestic production solves supply chain risks caused by trade disputes and foreign monopolies[cite: 307]. [cite_start]
- Technological Barrier: Our chemically defined medium ensures a 0% failure rate in GMP grades, creating a high entry barrier for competitors[cite: 306].
Contact Us
Whether you are interested in B2B partnerships for raw material supply or seeking clinical consultation, our team is ready to assist.
Global Headquarters
Centerpiece Bio
Leading the future of regenerative medicine.
📍 Gangnam Medical Center (HQ)
25, Soricheon-ro, Paju-si, Gyeonggi-do
Republic of Korea
(Yueun Tower 7th, District A, 5th Floor) [cite_start][cite: 849]
📞 Contact Lines
Inquiries: info@centerpiecebio.com
Clinical Center: +82-XX-XXX-XXXX